SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-068050
Filing Date
2024-06-03
Accepted
2024-06-03 16:35:10
Documents
11
Period of Report
2024-05-31
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgnx-20240531.htm   iXBRL 8-K 52044
  Complete submission text file 0000950170-24-068050.txt   162348

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgnx-20240531.xsd EX-101.SCH 23872
14 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-20240531_htm.xml XML 4522
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 241014200
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)